$ORMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ORAMED PHARMACEUTICALS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ORAMED PHARMACEUTICALS INC.. Get notifications about new insider transactions in ORAMED PHARMACEUTICALS INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Sell | J | 3.68 | 78,125 | 287,500 | 0 | 78.1 K to 0 (-100.00 %) |
| Mar 02 2021 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Sell | J | 3.68 | 375,000 | 1,380,000 | 0 | 375 K to 0 (-100.00 %) |
| Feb 17 2021 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
| Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
| Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 10.40 | 150,000 | 1,560,000 | 150,000 | |
| Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | Hexter Joshua | COO, Business Offic ... | Option Exercise | A | 10.40 | 50,000 | 520,000 | 50,000 | |
| Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | Gabay Avraham | CFO, Treasurer and ... | Option Exercise | A | 10.40 | 40,000 | 416,000 | 40,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Mayer Arie | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 4.80 | 190,000 | 912,000 | 190,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 4.80 | 100,000 | 480,000 | 100,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Xiaoming Gao | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Friedman Aviad | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | D | 4.17 | 10,000 | 41,700 | 0 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 3.16 | 196,500 | 620,940 | 196,500 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | D | 3.16 | 196,500 | 620,940 | 0 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 3.16 | 104,000 | 328,640 | 104,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | D | 3.16 | 104,000 | 328,640 | 0 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Gabay Avraham | CFO, Treasurer and ... | Option Exercise | A | 3.55 | 33,146 | 117,668 | 33,146 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Gabay Avraham | CFO, Treasurer and ... | Option Exercise | D | 3.55 | 33,146 | 117,668 | 0 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Hexter Joshua | Chf. Op. & Bus. Off ... | Option Exercise | A | 3.69 | 100,000 | 369,000 | 100,000 | |
| Sep 11 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 2.95 | 10,000 | 29,500 | 374,999 | 365 K to 375 K (+2.74 %) |
| Sep 11 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 2.90 | 15,000 | 43,500 | 364,999 | 350 K to 365 K (+4.29 %) |
| Jul 18 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 3.86 | 4,497 | 17,336 | 349,999 | 345.5 K to 350 K (+1.30 %) |
| Jul 18 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 3.74 | 10,020 | 37,497 | 345,502 | 335.5 K to 345.5 K (+2.99 %) |
| Jul 18 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 3.58 | 20,000 | 71,562 | 335,482 | 315.5 K to 335.5 K (+6.34 %) |
| Jul 18 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 3.47 | 20,000 | 69,316 | 315,482 | 295.5 K to 315.5 K (+6.77 %) |
| Jul 15 2019 | ORMP | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 3.22 | 1,320 | 4,250 | 295,482 | 294.2 K to 295.5 K (+0.45 %) |
| Jun 27 2019 | ORMP | ORAMED PHARMACEUTI ... | Gabay Avraham | CFO, Treasurer and ... | Option Exercise | A | 3.55 | 33,146 | 117,668 | 33,146 | |
| Apr 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Option Exercise | A | 4.13 | 20,000 | 82,600 | 20,000 | |
| Apr 12 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Feb 28 2019 | ORMP | ORAMED PHARMACEUTI ... | Hasleton Mark Daniel | VP Business Develop ... | Option Exercise | A | 3.16 | 22,500 | 71,100 | 22,500 | |
| Feb 28 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 3.16 | 104,000 | 328,640 | 104,000 | |
| Aug 13 2018 | ORMP | ORAMED PHARMACEUTI ... | Friedman Aviad | Director | Buy | P | 4.98 | 2,000 | 9,960 | 12,191 | 10.2 K to 12.2 K (+19.63 %) |
| Aug 13 2018 | ORMP | ORAMED PHARMACEUTI ... | Friedman Aviad | Director | Buy | P | 4.82 | 500 | 2,410 | 10,191 | 9.7 K to 10.2 K (+5.16 %) |
| Jul 12 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 5.92 | 122 | 722 | 958,209 | 958.1 K to 958.2 K (+0.01 %) |
| Jul 12 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Sell | S | 5.98 | 61 | 365 | 958,087 | 958.1 K to 958.1 K (-0.01 %) |
| May 07 2018 | ORMP | ORAMED PHARMACEUTI ... | Hexter Joshua | Chief Operating Off ... | Option Exercise | A | 6.70 | 30,000 | 201,000 | 30,000 | |
| May 07 2018 | ORMP | ORAMED PHARMACEUTI ... | Hexter Joshua | Chief Operating Off ... | Option Exercise | A | 6.70 | 30,000 | 201,000 | 30,000 | |
| Apr 10 2018 | ORMP | ORAMED PHARMACEUTI ... | Hexter Joshua | Chief Operating Off ... | Option Exercise | A | 7.05 | 30,000 | 211,500 | 30,000 | |
| Feb 02 2018 | ORMP | ORAMED PHARMACEUTI ... | Eisenberg Hilla | CFO, Treasurer and ... | Option Exercise | A | 8.14 | 15,000 | 122,100 | 15,000 | |
| Feb 02 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 8.14 | 97,000 | 789,580 | 97,000 | |
| Feb 02 2018 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 8.14 | 47,000 | 382,580 | 47,000 | |
| Nov 01 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Option Exercise | M | 3.77 | 16,892 | 63,609 | 0 | |
| Nov 01 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Buy | M | 3.77 | 16,892 | 63,609 | 1,316,328 | 1.3 M to 1.3 M (+1.30 %) |
| Oct 25 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | M | 6.00 | 6,373 | 38,238 | 0 | |
| Oct 25 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | M | 6.00 | 5,631 | 33,786 | 0 | |
| Oct 25 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | M | 6.00 | 6,373 | 38,238 | 294,162 | 287.8 K to 294.2 K (+2.21 %) |
| Oct 25 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | M | 6.00 | 5,631 | 33,786 | 287,789 | 282.2 K to 287.8 K (+2.00 %) |
| Aug 21 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Option Exercise | M | 3.77 | 112,613 | 424,056 | 0 | |
| Aug 21 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Buy | M | 3.77 | 112,613 | 424,056 | 1,299,436 | 1.2 M to 1.3 M (+9.49 %) |
| Aug 17 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | M | 6.00 | 11,262 | 67,572 | 0 | |
| Aug 17 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | M | 6.00 | 11,262 | 67,572 | 282,158 | 270.9 K to 282.2 K (+4.16 %) |
| Aug 03 2017 | IGVL | ORAMED PHARMACEUTI ... | Li Xiaopeng | Director | Buy | P | 8.50 | 89,636 | 761,906 | 206,350 | 116.7 K to 206.4 K (+76.80 %) |
| Aug 03 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Sell | S | 8.50 | 89,636 | 761,906 | 75,000 | 164.6 K to 75 K (-54.44 %) |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Zommer Yifat Hen | CFO, Treasurer and ... | Option Exercise | A | 7.77 | 20,001 | 155,408 | 20,001 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Option Exercise | A | 7.77 | 16,773 | 130,326 | 16,773 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 7.77 | 16,773 | 130,326 | 16,773 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 7.77 | 56,773 | 441,126 | 56,773 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 7.77 | 147,000 | 1,142,190 | 147,000 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 7.77 | 69,999 | 543,892 | 69,999 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Grant | A | 0.00 | 75,000 | 0 | 164,636 | 89.6 K to 164.6 K (+83.67 %) |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Li Xiaopeng | Director | Option Exercise | A | 7.77 | 16,773 | 130,326 | 16,773 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Friedman Aviad | Director | Option Exercise | A | 7.77 | 16,773 | 130,326 | 16,773 | |
| Apr 19 2017 | IGVL | ORAMED PHARMACEUTI ... | Li Xiaopeng | Director | Buy | P | 6.33 | 52,814 | 334,313 | 116,714 | 63.9 K to 116.7 K (+82.65 %) |
| Apr 19 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Sell | S | 6.33 | 52,814 | 334,313 | 89,636 | 142.5 K to 89.6 K (-37.08 %) |
| Mar 21 2017 | IGVL | ORAMED PHARMACEUTI ... | Law Ronald Edward | Chief Strategy Offi ... | Option Exercise | A | 6.00 | 37,152 | 222,912 | 37,152 | |
| Mar 02 2017 | IGVL | ORAMED PHARMACEUTI ... | Li Xiaopeng | Director | Option Exercise | A | 1.00 | 12,253 | 12,253 | 12,253 | |
| Mar 02 2017 | IGVL | ORAMED PHARMACEUTI ... | Friedman Aviad | Director | Option Exercise | A | 1.00 | 4,084 | 4,084 | 4,084 | |
| Feb 16 2017 | IGVL | ORAMED PHARMACEUTI ... | Slager David Mark | Director | Option Exercise | A | 6.23 | 5,697 | 35,492 | 5,697 | |
| Feb 16 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 6.23 | 5,697 | 35,492 | 5,697 | |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.59 | 3,300 | 21,763 | 15,061 | 11.8 K to 15.1 K (+28.06 %) |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.38 | 2,300 | 14,665 | 11,761 | 9.5 K to 11.8 K (+24.31 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.21 | 7,261 | 45,057 | 9,461 | 2.2 K to 9.5 K (+330.05 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.08 | 2,200 | 13,371 | 2,200 | 0 to 2.2 K |
| Nov 22 2016 | IGVL | ORAMED PHARMACEUTI ... | Hexter Joshua | Chief Operating Off ... | Grant | A | 0.00 | 70,000 | 0 | 70,000 | 0 to 70 K |
| Nov 07 2016 | IGVL | ORAMED PHARMACEUTI ... | Li Xiaopeng | Director | Grant | A | 7.42 | 63,900 | 474,138 | 63,900 | 0 to 63.9 K |
| May 23 2016 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 8.57 | 3,000 | 25,710 | 270,896 | 267.9 K to 270.9 K (+1.12 %) |
| May 12 2016 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 7.10 | 100 | 710 | 958,148 | 958 K to 958.1 K (+0.01 %) |
| May 12 2016 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 7.00 | 300 | 2,100 | 958,048 | 957.7 K to 958 K (+0.03 %) |
| May 12 2016 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.91 | 300 | 2,073 | 957,748 | 957.4 K to 957.7 K (+0.03 %) |
| May 12 2016 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.90 | 300 | 2,070 | 957,448 | 957.1 K to 957.4 K (+0.03 %) |
| Mar 14 2016 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Sell | S | 6.45 | 8,500 | 54,842 | 16,396 | 24.9 K to 16.4 K (-34.14 %) |
| Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.61 | 24,000 | 206,707 | 142,450 | 166.5 K to 142.5 K (-14.42 %) |
| Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.08 | 15,000 | 136,178 | 166,450 | 181.5 K to 166.5 K (-8.27 %) |
| Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.27 | 11,000 | 101,915 | 181,450 | 192.5 K to 181.5 K (-5.72 %) |
| Dec 28 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | X | 3.77 | 290,459 | 1,093,752 | 0 | |
| Dec 28 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | X | 3.77 | 290,459 | 1,093,752 | 1,186,823 | 896.4 K to 1.2 M (+32.40 %) |
| Dec 10 2015 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Sell | S | 9.44 | 700 | 6,608 | 22,896 | 23.6 K to 22.9 K (-2.97 %) |
| Dec 09 2015 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Sell | S | 8.70 | 761 | 6,621 | 23,596 | 24.4 K to 23.6 K (-3.12 %) |
| Dec 09 2015 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Sell | S | 8.70 | 539 | 4,689 | 24,357 | 24.9 K to 24.4 K (-2.17 %) |
| Oct 27 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 359 | 3,590 | 4,265 | |
| Oct 27 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 1,000 | 10,000 | 3,906 | |
| Oct 27 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 1,103 | 11,030 | 2,906 | |
| Oct 20 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 11 | 110 | 1,803 | |
| Oct 20 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 600 | 6,000 | 1,792 | |
| Oct 20 2015 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 10.00 | 1,192 | 11,920 | 1,192 | |
| May 12 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.64 | 100 | 664 | 957,148 | 957 K to 957.1 K (+0.01 %) |
| May 12 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.63 | 200 | 1,326 | 957,048 | 956.8 K to 957 K (+0.02 %) |
| May 12 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.62 | 100 | 662 | 956,848 | 956.7 K to 956.8 K (+0.01 %) |
| May 12 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 6.55 | 200 | 1,310 | 956,748 | 956.5 K to 956.7 K (+0.02 %) |
| Mar 20 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 4.00 | 100 | 400 | 956,548 | 956.4 K to 956.5 K (+0.01 %) |
| Mar 20 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 3.92 | 1,100 | 4,312 | 956,448 | 955.3 K to 956.4 K (+0.12 %) |
| Mar 20 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 3.95 | 400 | 1,580 | 955,348 | 954.9 K to 955.3 K (+0.04 %) |
| Mar 20 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 3.80 | 500 | 1,900 | 954,948 | 954.4 K to 954.9 K (+0.05 %) |
| Mar 20 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 3.78 | 500 | 1,890 | 954,448 | 953.9 K to 954.4 K (+0.05 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 0.00 | 22,178 | 0 | 267,896 | 245.7 K to 267.9 K (+9.03 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Grant | A | 0.00 | 22,178 | 0 | 24,896 | 2.7 K to 24.9 K (+815.97 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | OSTROV GERALD M | Director | Grant | A | 0.00 | 22,178 | 0 | 24,896 | 2.7 K to 24.9 K (+815.97 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | Zommer Yifat Hen | CFO, Treasurer and ... | Grant | A | 0.00 | 46,560 | 0 | 46,560 | 0 to 46.6 K |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Grant | A | 0.00 | 79,848 | 0 | 953,948 | 874.1 K to 953.9 K (+9.13 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Grant | A | 0.00 | 79,848 | 0 | 192,450 | 112.6 K to 192.5 K (+70.91 %) |
| Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Grant | A | 0.00 | 22,178 | 0 | 24,896 | 2.7 K to 24.9 K (+815.97 %) |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 0.00 | 2,718 | 0 | 245,718 | 243 K to 245.7 K (+1.12 %) |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | OSTROV GERALD M | Director | Grant | A | 0.00 | 2,718 | 0 | 2,718 | 0 to 2.7 K |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Grant | A | 0.00 | 9,788 | 0 | 112,602 | 102.8 K to 112.6 K (+9.52 %) |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Grant | A | 0.00 | 9,788 | 0 | 874,100 | 864.3 K to 874.1 K (+1.13 %) |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Grant | A | 0.00 | 2,718 | 0 | 2,718 | 0 to 2.7 K |
| Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Grant | A | 0.00 | 2,718 | 0 | 2,718 | 0 to 2.7 K |
| Sep 12 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.44 | 8,699 | 73,401 | 102,814 | 111.5 K to 102.8 K (-7.80 %) |
| Sep 12 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.40 | 23,000 | 193,260 | 111,513 | 134.5 K to 111.5 K (-17.10 %) |
| Sep 08 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.41 | 8,301 | 78,112 | 134,513 | 142.8 K to 134.5 K (-5.81 %) |
| Aug 01 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology O ... | Option Exercise | M | 0.01 | 142,814 | 1,714 | 0 | |
| Aug 01 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology O ... | Buy | M | 0.01 | 142,814 | 1,714 | 142,814 | 0 to 142.8 K |
| Jun 10 2014 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 4.44 | 2,252 | 9,999 | 1,453,637 | 1.5 M to 1.5 M (+0.16 %) |
| Apr 18 2014 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Buy | P | 14.41 | 700 | 10,087 | 700 | 0 to 700 |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 12.45 | 47,134 | 586,818 | 47,134 | |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | A | 12.45 | 47,134 | 586,818 | 47,134 | |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Option Exercise | A | 12.45 | 13,094 | 163,020 | 13,094 | |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 12.45 | 13,094 | 163,020 | 13,094 | |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | OSTROV GERALD M | Director | Option Exercise | A | 12.45 | 13,094 | 163,020 | 13,094 | |
| Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Option Exercise | A | 12.45 | 13,094 | 163,020 | 13,094 | |
| Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | M | 0.01 | 137,300 | 1,648 | 142,814 | |
| Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 12.03 | 137,300 | 1,651,582 | 0 | 137.3 K to 0 (-100.00 %) |
| Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Buy | M | 0.01 | 137,300 | 1,648 | 137,300 | 0 to 137.3 K |
| Apr 02 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Option Exercise | M | 5.76 | 6,100 | 35,136 | 18,900 | |
| Apr 02 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Option Exercise | M | 4.08 | 3,334 | 13,603 | 0 | |
| Apr 02 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Sell | S | 10.50 | 9,434 | 99,057 | 0 | 9.4 K to 0 (-100.00 %) |
| Apr 02 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Buy | M | 5.76 | 6,100 | 35,136 | 9,434 | 3.3 K to 9.4 K (+182.96 %) |
| Apr 02 2014 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Buy | M | 4.08 | 3,334 | 13,603 | 3,334 | 0 to 3.3 K |
| Mar 25 2014 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 10.90 | 47,300 | 515,551 | 1,451,385 | 1.4 M to 1.5 M (+3.37 %) |
| Mar 25 2014 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 10.15 | 27,700 | 281,257 | 1,404,085 | 1.4 M to 1.4 M (+2.01 %) |
| Feb 06 2014 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 14.96 | 26,800 | 400,941 | 1,376,385 | 1.3 M to 1.4 M (+1.99 %) |
| Feb 06 2014 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 16.32 | 24,492 | 399,798 | 1,349,585 | 1.3 M to 1.3 M (+1.85 %) |
| Jan 29 2014 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Sell | S | 15.00 | 834 | 12,510 | 0 | 834 to 0 (-100.00 %) |
| Jul 12 2013 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 7.40 | 6,630 | 49,034 | 1,325,093 | 1.3 M to 1.3 M (+0.50 %) |
| Jul 12 2013 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | L | 6.45 | 103 | 664 | 1,318,463 | 1.3 M to 1.3 M (+0.01 %) |
| Jul 12 2013 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | L | 6.40 | 447 | 2,861 | 1,318,360 | 1.3 M to 1.3 M (+0.03 %) |